These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 9335554

  • 1. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
    Panda D, Himes RH, Moore RE, Wilson L, Jordan MA.
    Biochemistry; 1997 Oct 21; 36(42):12948-53. PubMed ID: 9335554
    [Abstract] [Full Text] [Related]

  • 2. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
    Jordan MA, Walker D, de Arruda M, Barlozzari T, Panda D.
    Biochemistry; 1998 Dec 15; 37(50):17571-8. PubMed ID: 9860873
    [Abstract] [Full Text] [Related]

  • 3. Antiproliferative mechanism of action of cryptophycin-52: kinetic stabilization of microtubule dynamics by high-affinity binding to microtubule ends.
    Panda D, DeLuca K, Williams D, Jordan MA, Wilson L.
    Proc Natl Acad Sci U S A; 1998 Aug 04; 95(16):9313-8. PubMed ID: 9689077
    [Abstract] [Full Text] [Related]

  • 4. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
    Derry WB, Wilson L, Jordan MA.
    Cancer Res; 1998 Mar 15; 58(6):1177-84. PubMed ID: 9515803
    [Abstract] [Full Text] [Related]

  • 5. Mechanism of action cryptophycin. Interaction with the Vinca alkaloid domain of tubulin.
    Smith CD, Zhang X.
    J Biol Chem; 1996 Mar 15; 271(11):6192-8. PubMed ID: 8626409
    [Abstract] [Full Text] [Related]

  • 6. Cryptophycin: a new antimicrotubule agent active against drug-resistant cells.
    Smith CD, Zhang X, Mooberry SL, Patterson GM, Moore RE.
    Cancer Res; 1994 Jul 15; 54(14):3779-84. PubMed ID: 7913408
    [Abstract] [Full Text] [Related]

  • 7. Interaction of cryptophycin 1 with tubulin and microtubules.
    Kerksiek K, Mejillano MR, Schwartz RE, Georg GI, Himes RH.
    FEBS Lett; 1995 Dec 11; 377(1):59-61. PubMed ID: 8543019
    [Abstract] [Full Text] [Related]

  • 8. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
    Gupta K, Bishop J, Peck A, Brown J, Wilson L, Panda D.
    Biochemistry; 2004 Jun 01; 43(21):6645-55. PubMed ID: 15157098
    [Abstract] [Full Text] [Related]

  • 9. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
    Derry WB, Wilson L, Khan IA, Luduena RF, Jordan MA.
    Biochemistry; 1997 Mar 25; 36(12):3554-62. PubMed ID: 9132006
    [Abstract] [Full Text] [Related]

  • 10. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
    Madari H, Panda D, Wilson L, Jacobs RS.
    Cancer Res; 2003 Mar 15; 63(6):1214-20. PubMed ID: 12649179
    [Abstract] [Full Text] [Related]

  • 11. Interactions of antimitotic peptides and depsipeptides with tubulin.
    Hamel E.
    Biopolymers; 2002 Mar 15; 66(3):142-60. PubMed ID: 12385035
    [Abstract] [Full Text] [Related]

  • 12. Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.
    Edler MC, Buey RM, Gussio R, Marcus AI, Vanderwal CD, Sorensen EJ, Díaz JF, Giannakakou P, Hamel E.
    Biochemistry; 2005 Aug 30; 44(34):11525-38. PubMed ID: 16114889
    [Abstract] [Full Text] [Related]

  • 13. Localization of the antimitotic peptide and depsipeptide binding site on beta-tubulin.
    Mitra A, Sept D.
    Biochemistry; 2004 Nov 09; 43(44):13955-62. PubMed ID: 15518544
    [Abstract] [Full Text] [Related]

  • 14. Estramustine depolymerizes microtubules by binding to tubulin.
    Dahllöf B, Billström A, Cabral F, Hartley-Asp B.
    Cancer Res; 1993 Oct 01; 53(19):4573-81. PubMed ID: 8402630
    [Abstract] [Full Text] [Related]

  • 15. HTI-286, a synthetic analogue of the tripeptide hemiasterlin, is a potent antimicrotubule agent that circumvents P-glycoprotein-mediated resistance in vitro and in vivo.
    Loganzo F, Discafani CM, Annable T, Beyer C, Musto S, Hari M, Tan X, Hardy C, Hernandez R, Baxter M, Singanallore T, Khafizova G, Poruchynsky MS, Fojo T, Nieman JA, Ayral-Kaloustian S, Zask A, Andersen RJ, Greenberger LM.
    Cancer Res; 2003 Apr 15; 63(8):1838-45. PubMed ID: 12702571
    [Abstract] [Full Text] [Related]

  • 16. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM, Paul DC, Shih C, Jordan MA, Wilson L, Williams DC.
    Cancer Chemother Pharmacol; 1999 Apr 15; 43(2):115-25. PubMed ID: 9923816
    [Abstract] [Full Text] [Related]

  • 17. Stathmin family protein SCG10 differentially regulates the plus and minus end dynamics of microtubules at steady state in vitro: implications for its role in neurite outgrowth.
    Manna T, Grenningloh G, Miller HP, Wilson L.
    Biochemistry; 2007 Mar 20; 46(11):3543-52. PubMed ID: 17311410
    [Abstract] [Full Text] [Related]

  • 18. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
    ter Haar E, Kowalski RJ, Hamel E, Lin CM, Longley RE, Gunasekera SP, Rosenkranz HS, Day BW.
    Biochemistry; 1996 Jan 09; 35(1):243-50. PubMed ID: 8555181
    [Abstract] [Full Text] [Related]

  • 19. The synthetic compound CC-5079 is a potent inhibitor of tubulin polymerization and tumor necrosis factor-alpha production with antitumor activity.
    Zhang LH, Wu L, Raymon HK, Chen RS, Corral L, Shirley MA, Narla RK, Gamez J, Muller GW, Stirling DI, Bartlett JB, Schafer PH, Payvandi F.
    Cancer Res; 2006 Jan 15; 66(2):951-9. PubMed ID: 16424030
    [Abstract] [Full Text] [Related]

  • 20. Halohydrin analogues of cryptophycin 1: synthesis and biological activity.
    Georg GI, Ali SM, Stella VJ, Waugh WN, Himes RH.
    Bioorg Med Chem Lett; 1998 Aug 04; 8(15):1959-62. PubMed ID: 9873466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.